Page last updated: 2024-11-02
oxybutynin and Diseases, Peripheral Vascular
oxybutynin has been researched along with Diseases, Peripheral Vascular in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia." | 5.46 | The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017) |
| "Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia." | 1.46 | The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Aitken, E | 1 |
| McColl, G | 1 |
| Kingsmore, D | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| A Randonimised Trial Comparing Interrupted to Continuous Suturing Techniques in Radiocephalic Fistulae[NCT01704313] | | 70 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for oxybutynin and Diseases, Peripheral Vascular